Sign in
4

Changes in Ownership

NEKTAR THERAPEUTICS Filed Acc 0001209191-19-046428

SVP & Chief Financial Officer sold 25,000 shares at $17.79 ($444,750)

  • SVP & Chief Financial Officer acquired 25,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Labrucherie Gil M SVP & Chief Financial Officer 2019-08-14 Option exercise +25,000 $7.21 $180,250 152,935 D
Labrucherie Gil M SVP & Chief Financial Officer 2019-08-14 Sale −25,000 $17.79 $444,750 127,935 D
Derivatives
Labrucherie Gil M SVP & Chief Financial Officer 2019-08-14 Option exercise · Stock Option −25,000 0 D
Open-market sales · 25,000 sh · avg $17.79 · $444,750
Loading xslF345X03/doc4.xml…